Netflix acquires StoryBots to bring educational content to kids
Category: #headlines  By Mateen Dalal  Date: 2019-05-11
  • share
  • Twitter
  • Facebook
  • LinkedIn

Netflix acquires StoryBots to bring educational content to kids

Season 3 of “Ask the StoryBots” would be launched on Netflix in the fall.

The American media services provider Netflix Inc. has reportedly announced that it has acquired StoryBots, children's educational media franchise, to bring educational content to its growing member base of kids and families around the world. The move comes following the launch of highly anticipated rival Disney+.

Reportedly, the acquisition price of the deal is not yet disclosed by Netflix. But as per reliable sources, the price was immaterial to Netflix.

Generally, Netflix does not make acquisitions and prefers to spend directly on content. However, the streaming company rarely acquire content companies. The first acquisition made by Netflix was comic book creator MillarWorld in the year 2017.

“Ask the StoryBots”, a show of StoryBots, was first launched on Netflix in the year 2016. The show features 5 curious creatures who find answers to the questions that kids are often curious about, for example, why we brush our teeth, how night happens.

StoryBots has featured the voices of several celebs to accompany its animated characters, including Edward Norton, Snoop Dogg, Wanda Sykes and Whoopi Goldberg, among others.

Season 3 of “Ask the StoryBots” would be launched on Netflix in the fall.

Under the deal, more StoryBots original programming, including short-form content and additional series, will be produced by the Spiridellis brothers.

The larger goal of Netflix is to own a brand of popular kids’ educational programming – perhaps a Sesame Street for the Netflix era.

Another streaming services, such as Apple TV+ and HBO NOW, have already signed deals with Sesame workshop, the precedent which will have muppets teaching kids programming basics and the latter which now broadcasts Sesame Street.

Gregg and Evan Spiridellis reportedly stated that the company’s goal with Netflix is to make StoryBots the leading educational entertainment brand for families and kids around the world. The opportunity seems to be once-in-a-lifetime chance for the company to bring something epic into the world, he further added.

 

Source credit: https://techcrunch.com/2019/05/09/netflix-acquires-kids-educational-content-co-storybots/

https://media.netflix.com/en/press-releases/netflix-acquires-the-critically-and-fan-acclaimed-storybots-property-and-commits-to-bringing-educational-content-to-kids-and-families-around-the-world

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

Mateen has completed his Bachelor’s degree in electronics and telecommunication engineering, post which he lent his proficiency to the industry, working as a quality and test engineer. Drawn intricately toward the field of content creation however, Mateen soon switc...

Read More

More News By Mateen Dalal

Mercedes-AMG Petronas F1 Team and AMD team-up for F1 2020
Mercedes-AMG Petronas F1 Team and AMD team-up for F1 2020
By Mateen Dalal

Mercedes-AMG Petronas F1 Team, and Advanced Micro Devices (AMD), a renowned semiconductor developer, have reportedly announced a new multi-year partnership agreement that has combined the two firms’ passion of for high performance, beginning fr...

Aduro begins trial of MK-5890 for non-small cell lung cancer treatment
Aduro begins trial of MK-5890 for non-small cell lung cancer treatment
By Mateen Dalal

The biopharmaceutical giant has also received a USD 10 million development milestone payment from Merck & CO. for the initiation of the trial A clinical-stage biopharmaceutical company, Aduro Biotech, Inc. recently announced to have ba...

TherapeuticsMD submits a New Drug Application to the FDA for BIJUVA®
TherapeuticsMD submits a New Drug Application to the FDA for BIJUVA®
By Mateen Dalal

TherapeuticsMD, Inc., an inventive pharmaceutical company that focuses on women healthcare, has recently announced that it has presented a New Drug Application (NDA) pre-approval efficacy supplement to the U.S. FDA (Food and Drug Administration) for ...